Biolife Solutions (BLFS) Total Current Liabilities (2016 - 2025)
Biolife Solutions (BLFS) has disclosed Total Current Liabilities for 16 consecutive years, with $27.1 million as the latest value for Q3 2025.
- On a quarterly basis, Total Current Liabilities changed N/A to $27.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $27.1 million, a N/A change, with the full-year FY2024 number at $32.7 million, down 22.39% from a year prior.
- Total Current Liabilities was $27.1 million for Q3 2025 at Biolife Solutions, down from $28.3 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $47.3 million in Q1 2023 to a low of $16.4 million in Q1 2021.
- A 5-year average of $35.7 million and a median of $37.1 million in 2022 define the central range for Total Current Liabilities.
- Biggest YoY gain for Total Current Liabilities was 328.04% in 2021; the steepest drop was 35.66% in 2021.
- Biolife Solutions' Total Current Liabilities stood at $42.7 million in 2021, then grew by 4.41% to $44.6 million in 2022, then decreased by 5.39% to $42.2 million in 2023, then dropped by 22.39% to $32.7 million in 2024, then dropped by 17.07% to $27.1 million in 2025.
- Per Business Quant, the three most recent readings for BLFS's Total Current Liabilities are $27.1 million (Q3 2025), $28.3 million (Q2 2025), and $27.7 million (Q1 2025).